Togawa A - Search Results

1

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma.

Murakami H, Fujii H, Inaba T, Shimazaki C, Okamoto S, Miwa A, Sawamura M, Abe M, Chou T, Asaoku H, Kitahara Y, Hayashi K, Kosaka M, Togawa A, Takatsuki K; Japan Myeloma Study Group. Murakami H, et al. Among authors: togawa a. Eur J Haematol. 2004 Sep;73(3):169-73. doi: 10.1111/j.1600-0609.2004.00282.x. Eur J Haematol. 2004. PMID: 15287913 Clinical Trial.

2

[Thalidomide treatment of patients with refractory myeloma in the institutes participating in the Japan Myeloma Study Group].

Murakami H, Handa H, Imai K, Kanakura Y, Kosaka M, Sawamura M, Shimazaki C, Suzuki K, Ishii A, Takagi T, Taniwaki M, Togawa A, Hata H, Wakayama T, Takatsuki K; Japan Myeloma Study Group. Murakami H, et al. Among authors: togawa a. Rinsho Ketsueki. 2004 Jun;45(6):468-72. Rinsho Ketsueki. 2004. PMID: 15287523 Japanese.

3

Ten-year survival and prognostic factors in multiple myeloma. Japan Myeloma Study Group.

Tsuchiya J, Murakami H, Kanoh T, Kosaka M, Sezaki T, Mikuni C, Kawato M, Takagi T, Togawa A, Isobe T, et al. Tsuchiya J, et al. Among authors: togawa a. Br J Haematol. 1994 Aug;87(4):832-4. doi: 10.1111/j.1365-2141.1994.tb06745.x. Br J Haematol. 1994. PMID: 7986723

4

High serum lactate dehydrogenase level predicts short survival after vincristine-doxorubicin-dexamethasone (VAD) salvage for refractory multiple myeloma.

Suguro M, Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Matsuyama T, Takezako N, Miwa A, Togawa A. Suguro M, et al. Among authors: togawa a. Am J Hematol. 2000 Oct;65(2):132-5. doi: 10.1002/1096-8652(200010)65:2<132::aid-ajh7>3.0.co;2-l. Am J Hematol. 2000. PMID: 10996830 Free article.

5

Simple prognostic model for patients with multiple myeloma: a single-center study in Japan.

Kaneko M, Kanda Y, Oshima K, Nannya Y, Suguro M, Yamamoto R, Chizuka A, Hamaki T, Matsuyama T, Takezako N, Miwa A, Togawa A. Kaneko M, et al. Among authors: togawa a. Ann Hematol. 2002 Jan;81(1):33-6. doi: 10.1007/s00277-001-0388-5. Epub 2001 Nov 10. Ann Hematol. 2002. PMID: 11807633

6

Glucocorticoid receptor in multiple myeloma.

Murakami T, Togawa A, Satch H, Katoh M, Imamura Y, Ohsawa N, Takaku F. Murakami T, et al. Among authors: togawa a. Eur J Haematol. 1987 Jul;39(1):54-9. doi: 10.1111/j.1600-0609.1987.tb00164.x. Eur J Haematol. 1987. PMID: 3653372

7

Serial serum thrombopoietin levels in a pregnant woman with essential thrombocythaemia.

Kanda Y, Chiba S, Tanaka Y, Miwa A, Togawa A, Kato T, Miyazaki H, Nishino R, Yazaki Y, Hirai H. Kanda Y, et al. Among authors: togawa a. Br J Haematol. 1999 Apr;105(1):271-3. Br J Haematol. 1999. PMID: 10233392 Free article.

8

Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myeloma.

Kanda Y, Arai C, Chizuka A, Suguro M, Hamaki T, Yamamoto R, Yamauchi Y, Matsuyama T, Takezako N, Shirai Y, Miwa A, Iwasaki K, Nasu M, Togawa A. Kanda Y, et al. Among authors: togawa a. Leuk Lymphoma. 2000 Apr;37(3-4):445-9. doi: 10.3109/10428190009089447. Leuk Lymphoma. 2000. PMID: 10752998

9

Lack of correlation between clinical characteristics and serum soluble Fas ligand levels in patients with multiple myeloma.

Kanda Y, Ara C, Chizuka A, Yamamoto R, Hamaki T, Suguro M, Matsuyama T, Takezako N, Miwa A, Tohma J, Shirakawa K, Yatomi T, Nakamura N, Hirai H, Togawa A. Kanda Y, et al. Among authors: togawa a. Leuk Lymphoma. 2001 Jan;40(3-4):351-6. doi: 10.3109/10428190109057934. Leuk Lymphoma. 2001. PMID: 11426557

10

[Chemotherapy for multiple myeloma].

Togawa A. Togawa A. Nihon Rinsho. 1995 Mar;53(3):647-52. Nihon Rinsho. 1995. PMID: 7699899 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters